An International, Multi-Center, Open Label, Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix versus Goserelin Depot (Zoladex) in Men with Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Goserelin (Primary) ; Ozarelix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Spectrum Pharmaceuticals
- 10 Jun 2017 Biomarkers information updated
- 03 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.